PPIDT00211
Drug Information
| Name | Ruplizumab |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB06475 |
| Type | biotech |
| Indication | Investigated for use/treatment in thrombocytopenia, systemic lupus erythematosus, transplant (rejection), blood (blood forming organ disorders, unspecified), and multiple sclerosis. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| No dosage records. | ||